Asia Pacific Cancer Chemotherapy Market
Buy Now Request Sample Explore
Home › Report Store › Life Sciences  › Asia Pacific Cancer Chemotherapy Market

Asia Pacific Cancer Chemotherapy Market Outlook (2021–2031)

The Asia Pacific Cancer Chemotherapy Market size is expected to reach US$ 20,636.7 million by 2031 from US$ 8,214.8 million in 2024. The market is estimated to record a CAGR of 14.1% from 2025 to 2031.

Report Coverage
  • Therapy Type: Alkylating Agents, Antimetabolites, Anti-Tumor Antibiotics, Topoisomerase Inhibitors, Mitotic Inhibitors, Other Therapy Type
  • Indication: Blood Cancer, Lung Cancer, Breast Cancer, Colorectum Cancer, Prostate Cancer, Stomach Cancer, Cervical Cancer, Liver and Intrahepatic Bile Duct Cancer, Thyroid Cancer, Other Indications
  • End User: Hospital Pharmacies, Retail Pharmacies, Online Stores
US$ 8,214.8 Mn Market size in 2024
US$ 20,636.7 Mn Market Size by 2031
14.1% CAGR, 2025 - 2031
2025-2031 Forecast Period

1. Introduction

1.1 Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights
2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research
3.2 Primary Research
  • 3.2.1 Data Triangulation and Validation

4. Asia Pacific Cancer Chemotherapy Market Landscape

4.1 Overview
4.3 Ecosystem Analysis
  • 4.3.1 List of Vendors in the Value Chain

5. Asia Pacific Cancer Chemotherapy Market – Key Market Dynamics

5.1 Market Drivers
5.2 Market Restraints
5.3 Market Opportunities
5.4 Future Trends
5.5 Impact of Drivers and Restraints

6. Asia Pacific Cancer Chemotherapy Market Regional Analysis

6.2 Asia Pacific Cancer Chemotherapy Market Revenue 2021-2031 (US$ Million)
6.3 Asia Pacific Cancer Chemotherapy Market Forecast Analysis

7. Asia Pacific Cancer Chemotherapy Market Analysis – by Therapy Type

7.1 Alkylating Agents
  • 7.1.1 Overview
  • 7.1.2 Alkylating Agents: Asia Pacific Cancer Chemotherapy Market – Revenue and Forecast, 2021-2031 (US$ Million)
7.2 Antimetabolites
  • 7.2.1 Overview
  • 7.2.2 Antimetabolites: Asia Pacific Cancer Chemotherapy Market – Revenue and Forecast, 2021-2031 (US$ Million)
7.3 Anti-Tumor Antibiotics
  • 7.3.1 Overview
  • 7.3.2 Anti-Tumor Antibiotics: Asia Pacific Cancer Chemotherapy Market – Revenue and Forecast, 2021-2031 (US$ Million)
7.4 Topoisomerase Inhibitors
  • 7.4.1 Overview
  • 7.4.2 Topoisomerase Inhibitors: Asia Pacific Cancer Chemotherapy Market – Revenue and Forecast, 2021-2031 (US$ Million)
7.5 Mitotic Inhibitors
  • 7.5.1 Overview
  • 7.5.2 Mitotic Inhibitors: Asia Pacific Cancer Chemotherapy Market – Revenue and Forecast, 2021-2031 (US$ Million)
7.6 Other Therapy Type
  • 7.6.1 Overview
  • 7.6.2 Other Therapy Type: Asia Pacific Cancer Chemotherapy Market – Revenue and Forecast, 2021-2031 (US$ Million)

8. Asia Pacific Cancer Chemotherapy Market Analysis – by Indication

8.1 Blood Cancer
  • 8.1.1 Overview
  • 8.1.2 Blood Cancer: Asia Pacific Cancer Chemotherapy Market – Revenue and Forecast, 2021-2031 (US$ Million)
8.2 Lung Cancer
  • 8.2.1 Overview
  • 8.2.2 Lung Cancer: Asia Pacific Cancer Chemotherapy Market – Revenue and Forecast, 2021-2031 (US$ Million)
8.3 Breast Cancer
  • 8.3.1 Overview
  • 8.3.2 Breast Cancer: Asia Pacific Cancer Chemotherapy Market – Revenue and Forecast, 2021-2031 (US$ Million)
8.4 Colorectum Cancer
  • 8.4.1 Overview
  • 8.4.2 Colorectum Cancer: Asia Pacific Cancer Chemotherapy Market – Revenue and Forecast, 2021-2031 (US$ Million)
8.5 Prostate Cancer
  • 8.5.1 Overview
  • 8.5.2 Prostate Cancer: Asia Pacific Cancer Chemotherapy Market – Revenue and Forecast, 2021-2031 (US$ Million)
8.6 Stomach Cancer
  • 8.6.1 Overview
  • 8.6.2 Stomach Cancer: Asia Pacific Cancer Chemotherapy Market – Revenue and Forecast, 2021-2031 (US$ Million)
8.7 Cervical Cancer
  • 8.7.1 Overview
  • 8.7.2 Cervical Cancer: Asia Pacific Cancer Chemotherapy Market – Revenue and Forecast, 2021-2031 (US$ Million)
8.8 Liver and Intrahepatic Bile Duct Cancer
  • 8.8.1 Overview
  • 8.8.2 Liver and Intrahepatic Bile Duct Cancer: Asia Pacific Cancer Chemotherapy Market – Revenue and Forecast, 2021-2031 (US$ Million)
8.9 Thyroid Cancer
  • 8.9.1 Overview
  • 8.9.2 Thyroid Cancer: Asia Pacific Cancer Chemotherapy Market – Revenue and Forecast, 2021-2031 (US$ Million)
8.10 Other Indications
  • 8.10.1 Overview
  • 8.10.2 Other Indications: Asia Pacific Cancer Chemotherapy Market – Revenue and Forecast, 2021-2031 (US$ Million)

9. Asia Pacific Cancer Chemotherapy Market Analysis – by End User

9.1 Hospital Pharmacies
  • 9.1.1 Overview
  • 9.1.2 Hospital Pharmacies: Asia Pacific Cancer Chemotherapy Market – Revenue and Forecast, 2021-2031 (US$ Million)
9.2 Retail Pharmacies
  • 9.2.1 Overview
  • 9.2.2 Retail Pharmacies: Asia Pacific Cancer Chemotherapy Market – Revenue and Forecast, 2021-2031 (US$ Million)
9.3 Online Stores
  • 9.3.1 Overview
  • 9.3.2 Online Stores: Asia Pacific Cancer Chemotherapy Market – Revenue and Forecast, 2021-2031 (US$ Million)

10. Asia Pacific Cancer Chemotherapy Market – Asia-Pacific Analysis

10.1 Overview

10.2 Asia-Pacific
  • 10.2.1 Asia Pacific Cancer Chemotherapy Market Breakdown, by Key Country, 2025 and 2031 (%)
  • 10.2.1.1 Asia Pacific Cancer Chemotherapy Market – Revenue and Forecast Analysis – by Country
  • 10.2.1.1 Australia: Asia Pacific Cancer Chemotherapy Market – Revenue and Forecast to 2031 (US$ Million)
    • 10.2.1.1.1 Australia: Asia Pacific Cancer Chemotherapy Market Breakdown, by Therapy Type
    • 10.2.1.1.2 Australia: Asia Pacific Cancer Chemotherapy Market Breakdown, by Indication
    • 10.2.1.1.3 Australia: Asia Pacific Cancer Chemotherapy Market Breakdown, by End User
  • 10.2.1.2 China: Asia Pacific Cancer Chemotherapy Market – Revenue and Forecast to 2031 (US$ Million)
    • 10.2.1.2.1 China: Asia Pacific Cancer Chemotherapy Market Breakdown, by Therapy Type
    • 10.2.1.2.2 China: Asia Pacific Cancer Chemotherapy Market Breakdown, by Indication
    • 10.2.1.2.3 China: Asia Pacific Cancer Chemotherapy Market Breakdown, by End User
  • 10.2.1.3 India: Asia Pacific Cancer Chemotherapy Market – Revenue and Forecast to 2031 (US$ Million)
    • 10.2.1.3.1 India: Asia Pacific Cancer Chemotherapy Market Breakdown, by Therapy Type
    • 10.2.1.3.2 India: Asia Pacific Cancer Chemotherapy Market Breakdown, by Indication
    • 10.2.1.3.3 India: Asia Pacific Cancer Chemotherapy Market Breakdown, by End User
  • 10.2.1.4 Japan: Asia Pacific Cancer Chemotherapy Market – Revenue and Forecast to 2031 (US$ Million)
    • 10.2.1.4.1 Japan: Asia Pacific Cancer Chemotherapy Market Breakdown, by Therapy Type
    • 10.2.1.4.2 Japan: Asia Pacific Cancer Chemotherapy Market Breakdown, by Indication
    • 10.2.1.4.3 Japan: Asia Pacific Cancer Chemotherapy Market Breakdown, by End User
  • 10.2.1.5 South Korea: Asia Pacific Cancer Chemotherapy Market – Revenue and Forecast to 2031 (US$ Million)
    • 10.2.1.5.1 South Korea: Asia Pacific Cancer Chemotherapy Market Breakdown, by Therapy Type
    • 10.2.1.5.2 South Korea: Asia Pacific Cancer Chemotherapy Market Breakdown, by Indication
    • 10.2.1.5.3 South Korea: Asia Pacific Cancer Chemotherapy Market Breakdown, by End User
  • 10.2.1.6 Indonesia: Asia Pacific Cancer Chemotherapy Market – Revenue and Forecast to 2031 (US$ Million)
    • 10.2.1.6.1 Indonesia: Asia Pacific Cancer Chemotherapy Market Breakdown, by Therapy Type
    • 10.2.1.6.2 Indonesia: Asia Pacific Cancer Chemotherapy Market Breakdown, by Indication
    • 10.2.1.6.3 Indonesia: Asia Pacific Cancer Chemotherapy Market Breakdown, by End User
  • 10.2.1.7 Malaysia: Asia Pacific Cancer Chemotherapy Market – Revenue and Forecast to 2031 (US$ Million)
    • 10.2.1.7.1 Malaysia: Asia Pacific Cancer Chemotherapy Market Breakdown, by Therapy Type
    • 10.2.1.7.2 Malaysia: Asia Pacific Cancer Chemotherapy Market Breakdown, by Indication
    • 10.2.1.7.3 Malaysia: Asia Pacific Cancer Chemotherapy Market Breakdown, by End User
  • 10.2.1.8 Philippines: Asia Pacific Cancer Chemotherapy Market – Revenue and Forecast to 2031 (US$ Million)
    • 10.2.1.8.1 Philippines: Asia Pacific Cancer Chemotherapy Market Breakdown, by Therapy Type
    • 10.2.1.8.2 Philippines: Asia Pacific Cancer Chemotherapy Market Breakdown, by Indication
    • 10.2.1.8.3 Philippines: Asia Pacific Cancer Chemotherapy Market Breakdown, by End User
  • 10.2.1.9 Singapore: Asia Pacific Cancer Chemotherapy Market – Revenue and Forecast to 2031 (US$ Million)
    • 10.2.1.9.1 Singapore: Asia Pacific Cancer Chemotherapy Market Breakdown, by Therapy Type
    • 10.2.1.9.2 Singapore: Asia Pacific Cancer Chemotherapy Market Breakdown, by Indication
    • 10.2.1.9.3 Singapore: Asia Pacific Cancer Chemotherapy Market Breakdown, by End User
  • 10.2.1.10 Thailand: Asia Pacific Cancer Chemotherapy Market – Revenue and Forecast to 2031 (US$ Million)
    • 10.2.1.10.1 Thailand: Asia Pacific Cancer Chemotherapy Market Breakdown, by Therapy Type
    • 10.2.1.10.2 Thailand: Asia Pacific Cancer Chemotherapy Market Breakdown, by Indication
    • 10.2.1.10.3 Thailand: Asia Pacific Cancer Chemotherapy Market Breakdown, by End User
  • 10.2.1.11 Vietnam: Asia Pacific Cancer Chemotherapy Market – Revenue and Forecast to 2031 (US$ Million)
    • 10.2.1.11.1 Vietnam: Asia Pacific Cancer Chemotherapy Market Breakdown, by Therapy Type
    • 10.2.1.11.2 Vietnam: Asia Pacific Cancer Chemotherapy Market Breakdown, by Indication
    • 10.2.1.11.3 Vietnam: Asia Pacific Cancer Chemotherapy Market Breakdown, by End User
  • 10.2.1.12 Bangladesh: Asia Pacific Cancer Chemotherapy Market – Revenue and Forecast to 2031 (US$ Million)
    • 10.2.1.12.1 Bangladesh: Asia Pacific Cancer Chemotherapy Market Breakdown, by Therapy Type
    • 10.2.1.12.2 Bangladesh: Asia Pacific Cancer Chemotherapy Market Breakdown, by Indication
    • 10.2.1.12.3 Bangladesh: Asia Pacific Cancer Chemotherapy Market Breakdown, by End User
  • 10.2.1.13 New Zealand: Asia Pacific Cancer Chemotherapy Market – Revenue and Forecast to 2031 (US$ Million)
    • 10.2.1.13.1 New Zealand: Asia Pacific Cancer Chemotherapy Market Breakdown, by Therapy Type
    • 10.2.1.13.2 New Zealand: Asia Pacific Cancer Chemotherapy Market Breakdown, by Indication
    • 10.2.1.13.3 New Zealand: Asia Pacific Cancer Chemotherapy Market Breakdown, by End User
  • 10.2.1.14 Taiwan: Asia Pacific Cancer Chemotherapy Market – Revenue and Forecast to 2031 (US$ Million)
    • 10.2.1.14.1 Taiwan: Asia Pacific Cancer Chemotherapy Market Breakdown, by Therapy Type
    • 10.2.1.14.2 Taiwan: Asia Pacific Cancer Chemotherapy Market Breakdown, by Indication
    • 10.2.1.14.3 Taiwan: Asia Pacific Cancer Chemotherapy Market Breakdown, by End User

11. Competitive Landscape

11.1 Heat Map Analysis
11.2 Company Positioning and Concentration

12. Industry Landscape

12.1 Overview
12.2 Market Initiative
12.3 Partnerships and Collaborations
12.4 Other Developments

13. Company Profiles

13.1 Astellas Pharma Inc
  • 13.1.1 Key Facts
  • 13.1.2 Business Description
  • 13.1.3 Products and Services
  • 13.1.4 Financial Overview
  • 13.1.5 SWOT Analysis
  • 13.1.6 Key Developments
13.2 Eli Lilly and Co
  • 13.2.1 Key Facts
  • 13.2.2 Business Description
  • 13.2.3 Products and Services
  • 13.2.4 Financial Overview
  • 13.2.5 SWOT Analysis
  • 13.2.6 Key Developments
13.3 Novartis AG
  • 13.3.1 Key Facts
  • 13.3.2 Business Description
  • 13.3.3 Products and Services
  • 13.3.4 Financial Overview
  • 13.3.5 SWOT Analysis
  • 13.3.6 Key Developments
13.4 Merck KGaA
  • 13.4.1 Key Facts
  • 13.4.2 Business Description
  • 13.4.3 Products and Services
  • 13.4.4 Financial Overview
  • 13.4.5 SWOT Analysis
  • 13.4.6 Key Developments
13.5 Johnson & Johnson
  • 13.5.1 Key Facts
  • 13.5.2 Business Description
  • 13.5.3 Products and Services
  • 13.5.4 Financial Overview
  • 13.5.5 SWOT Analysis
  • 13.5.6 Key Developments
13.6 AstraZeneca
  • 13.6.1 Key Facts
  • 13.6.2 Business Description
  • 13.6.3 Products and Services
  • 13.6.4 Financial Overview
  • 13.6.5 SWOT Analysis
  • 13.6.6 Key Developments
13.7 Pfizer Inc
  • 13.7.1 Key Facts
  • 13.7.2 Business Description
  • 13.7.3 Products and Services
  • 13.7.4 Financial Overview
  • 13.7.5 SWOT Analysis
  • 13.7.6 Key Developments
13.8 Bristol Myers Squibb
  • 13.8.1 Key Facts
  • 13.8.2 Business Description
  • 13.8.3 Products and Services
  • 13.8.4 Financial Overview
  • 13.8.5 SWOT Analysis
  • 13.8.6 Key Developments
13.9 F. Hoffmann-La Roche Ltd
  • 13.9.1 Key Facts
  • 13.9.2 Business Description
  • 13.9.3 Products and Services
  • 13.9.4 Financial Overview
  • 13.9.5 SWOT Analysis
  • 13.9.6 Key Developments
13.10 AbbVie
  • 13.10.1 Key Facts
  • 13.10.2 Business Description
  • 13.10.3 Products and Services
  • 13.10.4 Financial Overview
  • 13.10.5 SWOT Analysis
  • 13.10.6 Key Developments

14. Appendix

14.1 About Business Market Insights
14.2 List of Abbreviations

Access the Full A Market Report

Get segment-level forecasts, regional estimates, competitive benchmarking, company profiles and downloadable Excel datasets.

Download Sample Request Customization
Access the full A Market Report
250 pages PDF & Excel | 2026-02-19
Download Sample Customization